Payload Delivery: Engineering Immune Cells to Disrupt the Tumour Microenvironment

SIMPLE SUMMARY: Cell-based therapies composed of genetically engineered immune cells have huge potential for treating cancer. T cells modified to express tumour-targeting receptors have been proven to be highly effective against blood cancers but not solid malignancies. Using innovative genetic modi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fowler, Daniel, Nattress, Callum, Navarrete, Alba Southern, Barisa, Marta, Fisher, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657158/
https://www.ncbi.nlm.nih.gov/pubmed/34885108
http://dx.doi.org/10.3390/cancers13236000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657158/
https://www.ncbi.nlm.nih.gov/pubmed/34885108
http://dx.doi.org/10.3390/cancers13236000

Ejemplares similares